Table 2.
Group | n | Incident Diabetes | Duration | Incidence a | Model 1 b | Model 2 c | Model 3 d | |
---|---|---|---|---|---|---|---|---|
Body weight variability (ASV) e | Q1 | 1,125,230 | 20,793 | 4,906,440.78 | 4.24 | 1.00 | 1.00 | 1.00 |
Q2 | 909,697 | 16,652 | 3,966,357.77 | 4.20 | 1.04 (1.02, 1.06) | 1.02 (1.001, 1.04) | 0.99 (0.97, 1.01) | |
Q3 | 838,844 | 16,384 | 3,647,718.23 | 4.49 | 1.13 (1.10, 1.15) | 1.09 (1.06, 1.11) | 1.01 (0.99, 1.03) | |
Q4 | 982,113 | 20,546 | 4,262,509.48 | 4.82 | 1.39 (1.36, 1.41) | 1.29 (1.27, 1.32) | 1.10 (1.07, 1.12) |
a Incidence rate per 1000 person-years; b Model 1 was non-adjusted; c Model 2 was adjusted for age, sex, smoking status, alcohol consumption, physical activity, income, hypertension, dyslipidemia, and fasting plasma glucose; d Model 3 was adjusted for the variables in model 2 plus baseline BMI e Q1, <1.00 kg; Q2, 1.00–1.66 kg; Q3, 1.67–2.65 kg; Q4, ≥2.67 kg.